A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults.

A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults.

Item
http://www.wikidata.org/entity/Q44195752
Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes)Scutellaria baicalensis decreases ritonavir-induced nauseaFusion activity of HIV gp41 fusion domain is related to its secondary structure and depth of membrane insertion in a cholesterol-dependent fashion.Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro.Pharmacokinetics of enfuvirtide in patients treated in typical routine clinical settings.Stem cell-based anti-HIV gene therapy.Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patientsA systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy.Genetic therapies against HIV.Use of fluorescence resonance energy transfer for rapid detection of enteroviral infection in vivo.
P2860

A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults.

Item
http://www.wikidata.org/entity/Q44195752
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A controlled Phase II trial as ...... tor-naive HIV-infected adults.
@en
A controlled Phase II trial as ...... tor-naive HIV-infected adults.
@nl
type
label
A controlled Phase II trial as ...... tor-naive HIV-infected adults.
@en
A controlled Phase II trial as ...... tor-naive HIV-infected adults.
@nl
prefLabel
A controlled Phase II trial as ...... tor-naive HIV-infected adults.
@en
A controlled Phase II trial as ...... tor-naive HIV-infected adults.
@nl
P1433
P1476
P2093
P304
P31
P433
P478
P50
P577
P698
P921
P1433
P1476
A controlled Phase II trial as ...... itor-naive HIV-infected adults
@en
P2093
P304
P31
P433
P478
P50
P577
P698
P921